Executive Wealth Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-70,324
Closed -$1.36M 191
2022
Q1
$1.36M Sell
70,324
-2,557
-4% -$58.6K 0.15% 107
2021
Q4
$2.38M Sell
72,881
-1,710
-2% -$68.8K 0.24% 86
2021
Q3
$3.06M Buy
74,591
+11,154
+18% +$405K 0.34% 81
2021
Q2
$2.28M Buy
+63,437
New +$2.34M 0.25% 87

Other funds holding GDRX

Executive Wealth Management's GDRX Position: Q2 2022 in Review

Executive Wealth Management sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 70,324 shares — an estimated $1.36M sold.

Executive Wealth Management first reported a position in GDRX in Q2 2021 and held it in 4 quarters. The position peaked at $3.06M in Q3 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

  • Executive Wealth Management reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
  • Executive Wealth Management sold 70,324 GoodRx Holdings shares in Q2 2022, an estimated $1.36M.
  • Executive Wealth Management first reported a position in GoodRx Holdings in Q2 2021 and held it in 4 quarters.
  • Executive Wealth Management's GoodRx Holdings position peaked at $3.06M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Executive Wealth Management's 13F filing for Q2 2022, filed 26 Jul 2022.